Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

Cathrine Ørskov; Siv A Hjorth; Anne Jensen; Tina Vilsbøll

doi:http://dx.doi.org/10.1016/j.regpep.2004.03.007

Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

Cathrine Ørskov, Siv A Hjorth, Anne Jensen, Tina Vilsbøll

2 Citations (Scopus)

Abstract

The enteroinsular-axis is abnormal in type 2 diabetics, which contributes to the diabetic phenotype. The effect of the incretin hormone gastric inhibitory polypeptide (GIP) and the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) are thus greatly diminished. The explanation for these changes could be changes in the structure of either of the hormones or their receptors. Thus, the aim of this study was to study the occurrence of genetic variants in the GIP and GLP-1 encoding regions of the proGIP and proglucagon genes in type 2 diabetic patients and matched control subjects.

Original language	English
Journal	Regulatory Peptides
Volume	119
Issue number	3
Pages (from-to)	151-4
Number of pages	4
ISSN	0167-0115
DOIs	https://doi.org/10.1016/j.regpep.2004.03.007
Publication status	Published - 15 Jul 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://dx.doi.org/10.1016/j.regpep.2004.03.007

Cite this

@article{f4654358f578489aa54cfc442ed8c60c,

title = "Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes",

abstract = "The enteroinsular-axis is abnormal in type 2 diabetics, which contributes to the diabetic phenotype. The effect of the incretin hormone gastric inhibitory polypeptide (GIP) and the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) are thus greatly diminished. The explanation for these changes could be changes in the structure of either of the hormones or their receptors. Thus, the aim of this study was to study the occurrence of genetic variants in the GIP and GLP-1 encoding regions of the proGIP and proglucagon genes in type 2 diabetic patients and matched control subjects.",

author = "Cathrine {\O}rskov and Hjorth, {Siv A} and Anne Jensen and Tina Vilsb{\o}ll",

year = "2004",

month = jul,

day = "15",

doi = "http://dx.doi.org/10.1016/j.regpep.2004.03.007",

language = "English",

volume = "119",

pages = "151--4",

journal = "Regulatory Peptides",

issn = "0167-0115",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

AU - Ørskov, Cathrine

AU - Hjorth, Siv A

AU - Jensen, Anne

AU - Vilsbøll, Tina

PY - 2004/7/15

Y1 - 2004/7/15

N2 - The enteroinsular-axis is abnormal in type 2 diabetics, which contributes to the diabetic phenotype. The effect of the incretin hormone gastric inhibitory polypeptide (GIP) and the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) are thus greatly diminished. The explanation for these changes could be changes in the structure of either of the hormones or their receptors. Thus, the aim of this study was to study the occurrence of genetic variants in the GIP and GLP-1 encoding regions of the proGIP and proglucagon genes in type 2 diabetic patients and matched control subjects.

AB - The enteroinsular-axis is abnormal in type 2 diabetics, which contributes to the diabetic phenotype. The effect of the incretin hormone gastric inhibitory polypeptide (GIP) and the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) are thus greatly diminished. The explanation for these changes could be changes in the structure of either of the hormones or their receptors. Thus, the aim of this study was to study the occurrence of genetic variants in the GIP and GLP-1 encoding regions of the proGIP and proglucagon genes in type 2 diabetic patients and matched control subjects.

U2 - http://dx.doi.org/10.1016/j.regpep.2004.03.007

DO - http://dx.doi.org/10.1016/j.regpep.2004.03.007

M3 - Journal article

SN - 0167-0115

VL - 119

SP - 151

EP - 154

JO - Regulatory Peptides

JF - Regulatory Peptides

IS - 3

ER -

Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this